Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

May 31, 2022

50715_rns_2022-05-31_558b5879-a9bc-43ca-95f0-7259265e4fa0.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

31 May 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase /Sale Totalnumberof sharesinvolved Total amountpaid / received Highest (H)prices paid/ received Lowest (L)prices paid/ received
ChinaInternationalCapitalCorporationLimited 30 May2022 Exchangetraded funds Dealing in pre-existingindex-trackingETFs Purchase 1,052,000 $3,038,288.1000 $2.9000 $2.8810
Exchangetraded funds Dealing in pre-existingindex-tracking ETFs Sale 1,121,800 $3,238,516.9000 $2.8990 $2.8800

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.